Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 13, Number 10—October 2007

Research

Antigenic Diversity of Human Sapoviruses

Grant S. Hansman*Comments to Author , Tomoichiro Oka*, Naomi Sakon†, and Naokazu Takeda*
Author affiliations: *National Institute of Infectious Diseases, Tokyo, Japan; †Osaka Prefectural Institute of Public Health, Osaka, Japan;

Main Article

Figure 3

Antibody ELISA absorbances at 492 nm of 6 viruslike particles (VLPs) of sapovirus. A) Mc114 GI/1; B) Yokote1 GI/5; C) Syd53 GII/3; D) Syd3 GIV/1; E) NK24 GV/1; F) NoV Osaka659. Wells were coated with ≈100 ng of purified VLPs. Antiserum was used in 2-fold dilutions from 1:500 to 1,024,000 in phosphate-buffered saline, 0.1% Tween 20, 5% skim milk shown as 1–12 along the x-axis. OD, optical density; NoV, Norwalk virus.

Figure 3. Antibody ELISA absorbances at 492 nm of 6 viruslike particles (VLPs) of sapovirus. A) Mc114 GI/1; B) Yokote1 GI/5; C) Syd53 GII/3; D) Syd3 GIV/1; E) NK24 GV/1; F) NoV Osaka659. Wells were coated with ≈100 ng of purified VLPs. Antiserum was used in 2-fold dilutions from 1:500 to 1,024,000 in phosphate-buffered saline, 0.1% Tween 20, 5% skim milk shown as 1–12 along the x-axis. OD, optical density; NoV, Norwalk virus.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO